Other biologics such as Benralizumab (anti-IL-5Rα), Dupilumab (anti-IL-4Rα), Mepolizumab (anti-IL-5), and Reslizumab (anti-IL-5) have been used in asthma patients and have demonstrated positive therapeutic effects in some cases. This evidence concerns the gene IL5 and asthma.